Enerplus (ERF) –
-
Eurofins Achieves Organic Growth of 6.8% in Q1 2024, Ahead of Its Objectives
-
Enerplus Corp. (ERF:CN) (ERF) PT Raised to Cdn$32 at Stifel Canada
-
Enerplus Corp. (ERF:CN) (ERF) PT Raised to Cdn$27 at Scotiabank
-
Form 6-K ENERPLUS Corp For: Apr 08
-
Form 6-K ENERPLUS Corp For: Apr 08
-
Chord Energy and Enerplus Announce Expiration of Hart-Scott-Rodino Act Waiting Period and Provide Transaction Update
-
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2024
-
The Eurofins Network Expands Its Offering in Renal and Transplant Testing in the United States With the Acquisition of Ascend Clinical LLC
-
Eurofins: Purchases of Own Shares from the 18th to the 22th of March 2024
-
Eurofins: Convening Notice of the Shareholders to the Annual Ordinary General Meeting and an Extraordinary General Meeting of the Company Valid as an Information Notice for the Bondholders
-
Eurofins: Purchases of Own Shares From the 11th to the 15th of March 2024
-
Form 6-K ENERPLUS Corp For: Mar 14
-
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 29 February 2024
-
Eurofins: Purchases of Own Shares From the 5th to the 8th of March 2024
-
Eurofins Discovery Introduces Innovative DiscoveryAI SAFIRE: A New AI-Driven Platform for Drug Discovery Trained Using Proprietary Datasets
-
Eurofins E&E and ETS-Lindgren Complete Half-Million-Dollar Expansion to Silicon Valley EMC Testing Facility
-
Form 6-K ENERPLUS Corp For: Feb 29
-
Eurofins Discovery Introduces Innovative DiscoveryAI SAFIRE: A New AI-Driven Platform for Drug Discovery Trained Using Proprietary Datasets
-
Enerplus Corp. (ERF:CN) (ERF) PT Lowered to Cdn$27.25 at Stifel Canada
-
Eurofins Delivers Strong Margin Improvement and Cash Generation in H2 2023 and Annual Results in Line With Its 2023 Objectives. Remains Confident to Achieve Its 2027 Objectives.
-
Form 6-K ENERPLUS Corp For: Feb 21
-
Desjardins Downgrades Enerplus Resources Fund (ERF) to Tender
-
Enerplus Corp. (ERF:CN) (ERF) PT Raised to Cdn$25.50 at Scotiabank
-
TD Securities Downgrades Enerplus Resources Fund (ERF) to Tender
-
Chord Energy (CHRD) and Enerplus (ERF) merge to form a $11 billion powerhouse
-
Form 6-K ENERPLUS Corp For: Feb 21
-
Form 6-K ENERPLUS Corp For: Feb 21
-
Form 6-K ENERPLUS Corp For: Feb 21
-
Form 6-K ENERPLUS Corp For: Feb 21
-
Form 6-K ENERPLUS Corp For: Feb 21
-
Enerplus (ERF) Reports Q4 EPS of Cdn$2.26; offers outlook
-
Form 40-F ENERPLUS Corp For: Dec 31
-
Chord Energy (CHRD), Enerplus (ERF) to merge in $11 billion deal
-
Chord Energy and Enerplus to Combine in $11 Billion Transaction Creating Premier Williston-Focused E&P Company with Top-Tier Shareholder Returns
-
Eurofins MET Labs Recognized for Instrumental Support in Intuitive Machines’ IM-1 Lunar Mission
-
Eurofins: Purchases of Own Shares from the 12th to the 14th of February 2024
-
Eurofins Scientific SE: Purchases of Own Shares from the 5th to the 9th of February 2024
-
Enerplus Corp. (ERF:CN) (ERF) PT Lowered to Cdn$27.75 at Stifel Canada
-
Exclusive-Shale producer Devon Energy in bid to acquire Enerplus -sources
-
Devon Energy (DVN) Has Approached Enerplus (ERF) With Acquisition Offer - Sources - Reuters
-
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 January 2024
-
Enerplus Corp. (ERF:CN) (ERF) PT Lowered to Cdn$27.75 at Stifel Canada
-
Eurofins: Purchases of Own Shares From the 29th of January to the 2nd of February 2024
-
Form 6-K ENERPLUS Corp For: Feb 02
-
Eurofins Environment Testing in Sacramento, CA in Partnership with EPA Region 10 and EPA’s Office of Water Published Draft Method 1634, an Analytical Procedure to Test for 6PPD-Quinone in Surface an
-
Eurofins: Purchases of Own Shares From the 22th of January to the 26th of January 2024
-
Stifel Canada Reiterates Buy Rating on Enerplus Corp. (ERF:CN) (ERF)
-
Form 6-K ENERPLUS Corp For: Jan 25
-
Eurofins: Purchases of Own Shares From the 15th of January to the 19 of January 2024
-
Eurofins CDMO Alphora Inc. Announces the Completion of a New Pilot Scale Biologics Development Facility
Back to ERF Stock Lookup
